Virios Therapeutics Inc
VIRI
Market Cap$206.5K
Close$
$0.18
14% upside
Current Fair Value
14% upsideUndervalued by 14% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $206,502.00 |
|---|---|
| Enterprise Value | $-16,193,911,498.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-368.93 |
| Beta | 1.58 |
| Outstanding Shares | 67,885,831 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.93 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.08 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Virios Therapeutics Inc
3 employeesVirios Therapeutics is a development-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia ('FM'). Overactive immune ...